Search research articles
Contact Us
Filters
Showing results (81-90 of 100) with videos related to
Page
of 10
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
May 2, 2022
Ultrasmall Nanoparticle Delivery of Doxorubicin Improves Therapeutic Index for High-Grade Glioma
Virginia Aragon-Sanabria, Anusha Aditya, Li Zhang, et al.
Human Gene Therapy. Clinical Development
|
February 8, 2018
AAVrh.10-Mediated APOE2 Central Nervous System Gene Therapy for APOE4-Associated Alzheimer's Disease
Jonathan B Rosenberg, Michael G Kaplitt, Bishnu P De, et al.
Human Gene Therapy
|
May 11, 2023
Identification of Safe and Effective Intravenous Dose of AAVrh.10hFXN to Treat the Cardiac Manifestations of Friedreich's Ataxia
Carlos Munoz-Zuluaga, Monica Gertz, Melissa Yost-Bido, et al.
Bioconjugate Chemistry
|
April 5, 2021
Engineered Cells as a Test Platform for Radiohaptens in Pretargeted Imaging and Radioimmunotherapy Applications
Megan M Dacek, Darren R Veach, Sarah M Cheal, et al.
Advanced Therapeutics
|
April 3, 2023
Engineered Ultrasmall Nanoparticle Drug-Immune Conjugates with "Hit and Run" Tumor Delivery to Eradicate Gastric Cancer
Li Zhang, Virginia Aragon-Sanabria, Anusha Aditya, et al.
Nature Communications
|
June 17, 2024
Cancer-associated Histone H3 N-terminal arginine mutations disrupt PRC2 activity and impair differentiation
Benjamin A Nacev, Yakshi Dabas, Matthew R Paul, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 22, 2020
A Self-Assembling and Disassembling (SADA) Bispecific Antibody (BsAb) Platform for Curative Two-step Pretargeted Radioimmunotherapy
Brian H Santich, Sarah M Cheal, Mahiuddin Ahmed, et al.
Cancer Research
|
June 15, 2026
Reprogramming of TLR-Ferroptosis Signaling and Immunometabolic Pathways Overcomes Myeloid Suppression to Improve Checkpoint Blockade in Prostate Cancer
Nabil A Siddiqui, Li Zhang, Gabriel DeLeon, et al.
Nature Communications
|
October 22, 2024
Author Correction: Cancer-associated Histone H3 N-terminal arginine mutations disrupt PRC2 activity and impair differentiation
Benjamin A Nacev, Yakshi Dabas, Matthew R Paul, et al.
Science Translational Medicine
|
May 30, 2014
Hematopoietic stem cell origin of BRAFV600E mutations in hairy cell leukemia
Stephen S Chung, Eunhee Kim, Jae H Park, et al.
Page
of 10
Search research articles
Search
Showing results (81-90 of 100) with videos related to
Sort By:
Page
of 10
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
May 2, 2022
Ultrasmall Nanoparticle Delivery of Doxorubicin Improves Therapeutic Index for High-Grade Glioma
Virginia Aragon-Sanabria, Anusha Aditya, Li Zhang, et al.
Human Gene Therapy. Clinical Development
|
February 8, 2018
AAVrh.10-Mediated APOE2 Central Nervous System Gene Therapy for APOE4-Associated Alzheimer's Disease
Jonathan B Rosenberg, Michael G Kaplitt, Bishnu P De, et al.
Human Gene Therapy
|
May 11, 2023
Identification of Safe and Effective Intravenous Dose of AAVrh.10hFXN to Treat the Cardiac Manifestations of Friedreich's Ataxia
Carlos Munoz-Zuluaga, Monica Gertz, Melissa Yost-Bido, et al.
Bioconjugate Chemistry
|
April 5, 2021
Engineered Cells as a Test Platform for Radiohaptens in Pretargeted Imaging and Radioimmunotherapy Applications
Megan M Dacek, Darren R Veach, Sarah M Cheal, et al.
Advanced Therapeutics
|
April 3, 2023
Engineered Ultrasmall Nanoparticle Drug-Immune Conjugates with "Hit and Run" Tumor Delivery to Eradicate Gastric Cancer
Li Zhang, Virginia Aragon-Sanabria, Anusha Aditya, et al.
Nature Communications
|
June 17, 2024
Cancer-associated Histone H3 N-terminal arginine mutations disrupt PRC2 activity and impair differentiation
Benjamin A Nacev, Yakshi Dabas, Matthew R Paul, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 22, 2020
A Self-Assembling and Disassembling (SADA) Bispecific Antibody (BsAb) Platform for Curative Two-step Pretargeted Radioimmunotherapy
Brian H Santich, Sarah M Cheal, Mahiuddin Ahmed, et al.
Cancer Research
|
June 15, 2026
Reprogramming of TLR-Ferroptosis Signaling and Immunometabolic Pathways Overcomes Myeloid Suppression to Improve Checkpoint Blockade in Prostate Cancer
Nabil A Siddiqui, Li Zhang, Gabriel DeLeon, et al.
Nature Communications
|
October 22, 2024
Author Correction: Cancer-associated Histone H3 N-terminal arginine mutations disrupt PRC2 activity and impair differentiation
Benjamin A Nacev, Yakshi Dabas, Matthew R Paul, et al.
Science Translational Medicine
|
May 30, 2014
Hematopoietic stem cell origin of BRAFV600E mutations in hairy cell leukemia
Stephen S Chung, Eunhee Kim, Jae H Park, et al.
Page
of 10